Cargando…
Matrine suppresses cardiac fibrosis by inhibiting the TGF-β/Smad pathway in experimental diabetic cardiomyopathy
Cardiac fibrosis is one of the pathological characteristics of diabetic cardiomyopathy (DbCM). Matrine treatment has proven to be effective in cases of organ fibrosis and cardiovascular diseases. In the present study, the anti-fibrosis-associated cardioprotective effects of matrine on DbCM were inve...
Autores principales: | Zhang, Yong, Cui, Lei, Guan, Gongchang, Wang, Junkui, Qiu, Chuan, Yang, Tielin, Guo, Yan, Liu, Zhongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780122/ https://www.ncbi.nlm.nih.gov/pubmed/29138820 http://dx.doi.org/10.3892/mmr.2017.8054 |
Ejemplares similares
-
Matrine Suppresses Pancreatic Fibrosis by Regulating TGF-β/Smad Signaling in Rats
por: Liu, Pi, et al.
Publicado: (2019) -
Matrine‐Type Alkaloids Inhibit Advanced Glycation End Products Induced Reactive Oxygen Species‐Mediated Apoptosis of Aortic Endothelial Cells In Vivo and In Vitro by Targeting MKK3 and p38MAPK Signaling
por: Liu, Zhongwei, et al.
Publicado: (2017) -
Discovery of Matrinic Thiadiazole Derivatives as a Novel Family of Anti-Liver Fibrosis Agents via Repression of the TGFβ/Smad Pathway
por: Niu, Tianyu, et al.
Publicado: (2018) -
Design and Synthesis of Matrine Derivatives as Novel Anti-Pulmonary Fibrotic Agents via Repression of the TGFβ/Smad Pathway
por: Li, Lingyu, et al.
Publicado: (2019) -
Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
por: Wang, Yinhui, et al.
Publicado: (2021)